SAT-209
/ Satya Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 29, 2026
SAT209. Advancing Pulse Oximetry: Innovation, Performance, and Equity (Non-CME)
(ASA 2026)
- "Explore how perioperative conditions influence pulse oximetry performance and clinical decisions, and how technology equity, evolving standards, rigorous verification, and innovation are advancing pulse oximetry. Supported by Medtronic"
1 to 1
Of
1
Go to page
1